Influence of Renal Impairment on the Pharmacokinetics of Afatinib: An Open-Label, Single-Dose Study
Crossref DOI link: https://doi.org/10.1007/s13318-016-0359-9
Published Online: 2016-07-19
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wiebe, Sabrina
Schnell, David
Külzer, Raimund
Gansser, Dietmar
Weber, Anne
Wallenstein, Gudrun
Halabi, Atef
Conrad, Anja
Wind, Sven
Funding for this research was provided by:
Boehringer Ingelheim
License valid from 2016-07-19